Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4,100.00p
   
  • Change Today:
    -90.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,251
  • Market Cap: £213.58m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 518,176 £21,245,216
Ian James Nicholson 15,500 £635,500

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £40,385,000
Liontrust Investment Partners LLP 522,952 £21,441,032
Canaccord Genuity Group Inc 512,143 £20,997,863
Miton Group plc 508,135 £20,833,535
The Diverse Income Trust plc 302,300 £12,394,300
Wasatch Advisors, Inc. 265,000 £10,865,000
Gresham House Asset Management Limited 259,116 £10,623,756
Adrian Williams 253,372 £10,388,252
Danske Bank A/S 168,132 £6,893,412

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,100.00p
Change Today -90.00p
% Change -2.15 %
52 Week High 4,500.00
52 Week Low 3,800.00
Volume 2,251
Shares Issued 5.21m
Market Cap £213.58m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average
Price Trend
52.96% below the market average52.96% below the market average52.96% below the market average52.96% below the market average52.96% below the market average
49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average
Income Not Available
Growth
77.46% above the market average77.46% above the market average77.46% above the market average77.46% above the market average77.46% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 23-Jun-2021

Time Volume / Share Price
15:53 5 @ 4,100.00p
15:46 9 @ 4,065.00p
15:42 109 @ 4,050.00p
15:39 105 @ 4,050.00p
15:32 371 @ 4,050.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page